| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 北芯生命成立于2015年12月，总部位于深圳市，在深圳、香港、荷兰等地设子公司，北京、上海、广州设有分公司，凝聚了国际、国内500余位具有丰富医疗器械产业经验和创新能力的人才，专注于心血管疾病精准诊疗创新医疗器械研发、生产和销售。 北芯生命已在境内外累积获批了20余张Ⅲ类医疗器械注册证，核心产品包括中国首个获批的国产60MHz高清高速血管内超声(IVUS)系统、中国首个获批的国产金标准血流储备分数(FFR)系统，形成了智能化心血管精准介入解决方案，提升了心血管精准诊疗在我国的可及性，有助于改善心血管疾病患者的生命健康。 如今，北芯的心血管精准介入解决方案已进入全球1000多家医院。 | ||||||||||||||||||||||||
| Main Business | 心血管疾病精准诊疗创新医疗器械研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | 宋亮 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 罗睿 | ||||||||||||||||||||||||
| Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
| Auditors | 容诚会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 86-755-23201921 | ||||||||||||||||||||||||
| Fax No | 86-755-23575621 | ||||||||||||||||||||||||
| Website | www.insight-med.com | ||||||||||||||||||||||||
| ir@insight-med.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 05/02/2026 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.120 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 1.910 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.842B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |